Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 481 AL 495

Innovations in Functional Neurosurgery and Anesthetic Implications

Dunn LK, Durieux ME, Elias WJ, Nemergut EC, Naik BI.

J Neurosurg Anesthesiol. 2018 Jan;30(1):18-25. doi: 10.1097/ANA.0000000000000398.

TDP-43 Prions

Nonaka T, Hasegawa M.

Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):a024463. doi: 10.1101/cshperspect.a024463.

Cell Biology and Pathophysiology of α-Synuclein

Burré J, Sharma M, Südhof TC.

Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):a024091. doi: 10.1101/cshperspect.a024091.

Genetics of Synucleinopathies

Nussbaum RL.

Cold Spring Harb Perspect Med. 2018 Jun 1;8(6):a024109. doi: 10.1101/cshperspect.a024109.

Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases

Russo R, Cristiano C, Avagliano C, De Caro C, La Rana G, Raso GM, Canani RB, Meli R, Calignano A.

Curr Med Chem. 2018;25(32):3930-3952. doi: 10.2174/0929867324666170216113756.

Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders

Grant Liska M, Crowley MG, Lippert T, Corey S, Borlongan CV.

Handb Exp Pharmacol. 2018;247:277-299. doi: 10.1007/164_2017_7.

The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases

Zhang G, Khan AA, Wu H, Chen L, Gu Y, Gu N.

Curr Drug Targets. 2018 Feb 8;19(3):279-298. doi: 10.2174/1389450118666170328115801.

[King's Parkinson's disease pain scale : Intercultural adaptation in the German language]

Jost WH, Rizos A, Odin P, Löhle M, Storch A.

Nervenarzt. 2018 Feb;89(2):178-183. doi: 10.1007/s00115-017-0333-z.

Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update

Cau Y, Valensin D, Mori M, Draghi S, Botta M.

Curr Med Chem. 2018;25(1):5-21. doi: 10.2174/0929867324666170426095015.

Brain inflammasomes in stroke and depressive disorders: Regulation by oestrogen

Slowik A, Lammerding L, Hoffmann S, Beyer C.

J Neuroendocrinol. 2018 Feb;30(2). doi: 10.1111/jne.12482.

Levodopa in Parkinson's Disease: Current Status and Future Developments

Tambasco N, Romoli M, Calabresi P.

Curr Neuropharmacol. 2018;16(8):1239-1252. doi: 10.2174/1570159X15666170510143821.

Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases

Lanza V, Milardi D, Di Natale G, Pappalardo G.

Curr Med Chem. 2018 Feb 12;25(4):525-539. doi: 10.2174/0929867324666170518094404.

Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?

Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M.

Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127.

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases

Penke B, Fulop L, Szucs M, Frecska E.

Curr Neuropharmacol. 2018;16(1):97-116. doi: 10.2174/1570159X15666170529104323.

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

Abushouk AI, Negida A, Elshenawy RA, Zein H, Hammad AM, Menshawy A, Mohamed WMY.

CNS Neurol Disord Drug Targets. 2018 Apr 26;17(1):14-21. doi: 10.2174/1871527316666170602101538.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias